Hormone Therapy

Opioid-induced androgen deficiency in men: Prevalence, pathophysiology, and efficacy of testosterone therapy.

TL;DR

Chronic opioid use is a common but underappreciated cause of androgen deficiency in men, with prevalence varying between 20% and 80%, and limited clinical trial data suggest testosterone therapy improves libido, body composition, and quality of life while early evidence indicates anti-nociceptive properties.

Key Findings

The prevalence of opioid-induced androgen deficiency in men varies widely between 20% and 80%.

  • Prevalence is influenced by the type of opioid used, duration of exposure, age of the cohort, and how low testosterone was defined.
  • Despite its high prevalence, this adverse effect of chronic opioid use remains underappreciated by clinicians.
  • As a result, androgen deficiency remains underdiagnosed and likely undertreated.
  • Literature reviewed spanned from 1950 through June 2024.

Opioids suppress the gonadal axis primarily by inhibiting GnRH synthesis and secretion.

  • The mechanism is described as inhibition of gonadotropin-releasing hormone (GnRH) synthesis and secretion.
  • This represents a central (hypothalamic) mechanism of androgen suppression.
  • The resulting condition is classified as opioid-induced androgen deficiency.

Testosterone therapy in men with opioid-induced androgen deficiency improves libido, body composition, and certain domains of quality of life.

  • These findings are based on 'limited data from clinical trials.'
  • The review characterizes the available clinical trial evidence as limited.
  • Testosterone therapy could be considered in men with 'unequivocal androgen deficiency after a thorough clinical evaluation.'

Early evidence suggests that testosterone has anti-nociceptive properties in men with opioid-induced androgen deficiency.

  • This finding is described as 'early evidence' from clinical studies.
  • The anti-nociceptive properties of testosterone confirm findings from preclinical and population studies.
  • Ongoing clinical trials are expected to shed further light on the efficacy of testosterone therapy, particularly regarding its anti-nociceptive effects.
  • Anti-nociceptive effects of testosterone were identified as a particular focus of the review.

There is a recognized need to raise awareness among clinicians regarding opioid-induced androgen deficiency as an adverse effect of opioid use.

  • Opioid analgesics are frequently prescribed for the treatment of chronic pain.
  • The adverse effect of androgen deficiency 'remains underappreciated by clinicians.'
  • The condition is described as 'a common but underappreciated cause of androgen deficiency in men.'
  • Key search terms used were 'opioids,' 'hypogonadism,' 'low testosterone,' and 'testosterone therapy,' with sources from PubMed and references within retrieved publications.

Have a question about this study?

Citation

Kafel H, Braga-Basaria M, Basaria S. (2025). Opioid-induced androgen deficiency in men: Prevalence, pathophysiology, and efficacy of testosterone therapy.. Andrology. https://doi.org/10.1111/andr.70013